FDA staff reviewing Musk’s Neuralink were included in DOGE employee firings, sources say
- About 20 employees from the FDA's office of Neurological and Physical Medicine Devices were fired, including some involved with Neuralink, as reported by two sources.
- The layoffs raised concerns about the FDA's ability to safely process medical device applications, according to external experts and sources familiar with the matter.
- Concerns were expressed that the layoffs could be intimidating for the FDA professionals overseeing Neuralink's trial, raising worries about trial safety.
- Neuralink is testing its device that enables paralyzed individuals to control digital devices with their thoughts, having received FDA approval for its first human clinical trial in May 2023.
Insights by Ground AI
Does this summary seem wrong?
27 Articles
27 Articles
All
Left
12
Center
5
Right
3
Coverage Details
Total News Sources27
Leaning Left12Leaning Right3Center5Last UpdatedBias Distribution60% Left
Bias Distribution
- 60% of the sources lean Left
60% Left
L 60%
C 25%
15%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage